These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2249019)

  • 41. Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.
    Brunello A; Rizzato MD; Rastrelli M; Roma A; Maruzzo M; Basso U; Fiduccia P; Buzzaccarini MS; Scarzello G; Rossi CR; Zagonel V
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):679-85. PubMed ID: 26547435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma].
    Amodio A; Carpano S; Paoletti G; Gionfra T; Rinaldi M; Manfredi C; Foggi P; Lopez M
    Clin Ter; 1998; 149(2):121-5. PubMed ID: 9780476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma.
    Chawla SP; Goel S; Chow W; Braiteh F; Singh AS; Olson JEG; Osada A; Bobe I; Riedel RF
    Clin Cancer Res; 2020 Aug; 26(16):4225-4232. PubMed ID: 32381487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.
    de Vries EG; Greidanus J; Mulder NH; Nieweg MB; Postmus PE; Schipper DL; Sleijfer DT; Uges DR; Willemse PH
    J Clin Oncol; 1987 Sep; 5(9):1445-51. PubMed ID: 3476690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verwey J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):311-21. PubMed ID: 3595691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study.
    Carmo-Pereira J; Costa FO; Miles DW; Henriques E; Richards MA; Rubens RD
    Cancer Chemother Pharmacol; 1991; 27(5):394-6. PubMed ID: 1999000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
    Casper ES; Christman KL; Schwartz GK; Johnson B; Brennan MF; Bertino JR
    Cancer; 1993 Aug; 72(3):766-70. PubMed ID: 8392904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Polychemotherapy of advanced soft tissue sarcomas with 4'-epi-doxorubicin (4'-Epi-DX) and cisplatin (DDP)].
    Sauer H; Mair W; Fink U; Rückle H; Mjaaland I; Wilmanns W
    Onkologie; 1986 Aug; 9 Suppl 1():24-8. PubMed ID: 3528967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
    Borden EC; Amato DA; Edmonson JH; Ritch PS; Shiraki M
    Cancer; 1990 Sep; 66(5):862-7. PubMed ID: 2201431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer.
    Macchiarini P; Danesi R; Mariotti R; Marchetti A; Fazzi P; Bevilacqua G; Mariani M; Giuntini C; Del Tacca M; Angeletti CA
    Am J Clin Oncol; 1990 Aug; 13(4):302-7. PubMed ID: 2165738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study with high doses of epirubicin in patients with advanced rectal cancer.
    Alberola V; García Conde J; Jimeno J; Fernandez Martos C; Herranz C; Macheng I; Centelles M; Sánchez J
    Tumori; 1990 Oct; 76(5):503-4. PubMed ID: 2256199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
    Buesa JM; Mouridsen HT; van Oosterom AT; Verweij J; Wagener T; Steward W; Poveda A; Vestlev PM; Thomas D; Sylvester R
    Ann Oncol; 1991 Apr; 2(4):307-9. PubMed ID: 1868027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trials of tetrahydropyranyl-adriamycin (Pirarubicin) on renal and colon carcinoma, melanoma, and soft tissue sarcoma.
    Roché H; Guiochet N; Kerbrat P; Rebattu P; Fargeot P; Cattan A; Armand JP; Keiling R; Lentz MA; Van Glabeke M
    Am J Clin Oncol; 1993 Apr; 16(2):137-9. PubMed ID: 8452105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single agent epirubicin in squamous cell cervical cancer. A phase II trial.
    Calero F; Rodriguez-Escudero F; Jimeno J; Mendaña J; Iglesias J; Murillo F; Ugalde F; Armas A; Rementeria A; Asins J
    Acta Oncol; 1991; 30(3):325-7. PubMed ID: 2036241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
    Pivot X; Chevreau C; Cupissol D; Lortholary A; Bui NB; Eymard JC; Bay JO; Baranzelli MC; Mita M; Barnouin L; Savary J; Thyss A
    Am J Clin Oncol; 2002 Dec; 25(6):561-4. PubMed ID: 12477998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of high-dose epirubicin in advanced non-small cell lung cancer.
    Martoni A; Melotti B; Guaraldi M; Pannuti F
    Eur J Cancer; 1991; 27(10):1231-4. PubMed ID: 1659841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase II multicenter study of epirubicin for hormone-resistant prostatic cancer with measurable soft tissue disease.
    Tannock IF; Erwin TJ; Stewart DJ; Fontaine B; Gupta S
    Am J Clin Oncol; 1993 Apr; 16(2):156-8. PubMed ID: 8452110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epirubicin: a phase II study in recurrent small-cell lung cancer.
    Rosenthal M; Kefford R; Raghavan D; Stuart-Harris R
    Cancer Chemother Pharmacol; 1991; 28(3):220-2. PubMed ID: 1713130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS.
    Shepherd FA; Burkes RL; Paul KE; Goss PE
    AIDS; 1991 Mar; 5(3):305-9. PubMed ID: 2059370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.